FDA Inspection
Biomat USA Inc. dba GrifolsBiomat USA Inc. dba Grifols – FDA Inspection, Apr 2, 2010
Record Details
This FDA Inspection record concerns Biomat USA Inc. dba Grifols, with an inspection on April 2, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA Inc. dba Grifols
- Inspection Date
- April 2, 2010
- Product Type
- Biologics
View Company Profile
ID · 9807d087-3e40-497d-a48b-391bb0028e64
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 657028
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc. dba Grifols
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 23, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 6, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc. dba Grifols
- FDA Inspection 1056459 - 2018-05-15
- FDA Inspection 983369 - 2016-08-23
- FDA Inspection 872913 - 2014-04-03
- FDA Inspection 793967 - 2012-08-06
- FDA Inspection 746801 - 2011-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.